This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A year of trastuzumab emtansine (T‑DM1) can keep about 98% of women with small, early‑stage ...
Stocktwits on MSN
Merck stock gains on positive EU opinion for cancer therapy
EU regulators backed the combo based on strong Phase 3 data showing improvements across survival and tumor response outcomes.
May is National Women’s Health Month, and The Bar founder is using her platform to encourage women to check their breasts.
"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...
Hall of Fame broadcaster Dick Vitale is making progress from his battle against lung cancer, which is his fifth against the ...
The likelihood of EGFR-positive lung cancer returning is largely tied to how advanced it is when first diagnosed, with lower chances in early stages and higher odds in later stages. Newer targeted ...
New approvals for fam-trastuzumab deruxtecan-nxki establish a potential new standard of care in the neoadjuvant and adjuvant settings for patients with HER2-positive early breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results